Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Thank you both Ron and CANTWAIT

Caintwait had the description of what I was thinking. Currently PTSC is allowed to by a certain percent of average daily volume or something like that. They can only buy so many shares. But a fixed price tender offer would give them a method of taking out a large chunk of outstanding shares. Remember how they have issued millions of shares to assist in mergers and acquisitions or just to keep the doors open? With MMP licensing funds coming in, they could reduce outstanding shares before paying dividends.

Share
New Message
Please login to post a reply